Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The James Lind Alliance Priority Setting Partnership will identify the uncertainties that surround bipolar disorder.

Patients, carers and clinicians across Oxfordshire and the Thames Valley are being given the opportunity to identify future research priorities for biopolar disorder through the new James Lind Alliance Priority Setting Partnership (PSP).

Researchers from the NIHR CLARHC Oxford will bring their expertise to the recently launched partnership to identify questions about bipolar disorder causes, diagnosis, treatment, care and prognosis which have yet to be answered by research.

Following a widely distributed survey this October to uncover the key themes, a partner workshop aims to debate the issues and generate a list of the top 10 most pressing research questions, with the view to obtain funding to investigate these further.

Professor Richard Hobbs, NIHR CLAHRC Oxford Director said:

“The CLARHC exists to bring together key leaders in healthcare research and practice across the region to improve the delivery of health and patient care. We are delighted to bring our own local expertise to the James Lind Alliance partnership and help shape the future direction of bipolar disorder research.”

David Crowe, James Lind Alliance Advisor said:

“This PSP is being set up at a time when new technologies and approaches to understanding bipolar disorder are becoming available. These advances expand the scope of research making it more important than ever that future research priorities are set by people with personal or professional experience of bipolar disorder.”

Coordinated by the NIHR Oxford BRC JLA Hub, the PSP is funded by Leeds and York Partnership NHS Foundation Trust. NIHR CLAHRC Oxford joins other partners including Bipolar UK, SANE, Service User Research Enterprise (SURE), Oxford Health NHS Foundation Trust, University of Oxford, the Cochrane Collaboration Depression, Anxiety and Neurosis Group and MQ.